OTCMKTS:RDSMY - Koninklijke DSM Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 9
  • Breakdown:
  • 2 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$42.27
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Koninklijke DSM Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RDSMY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RDSMY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Koninklijke DSM in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $42.27.
Hold
The current consensus among 9 contributing investment analysts is to hold stock in Koninklijke DSM. This rating has held steady since December 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 2 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 2 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 2 sell ratings
2/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/17/2021BarclaysReiterated RatingOverweight
i
2/17/2021UBS GroupReiterated RatingBuy
i
2/17/2021Credit Suisse GroupReiterated RatingOutperform
i
1/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform
i
1/12/2021Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
i
11/10/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
11/4/2020Credit Suisse GroupReiterated RatingNeutral
i
10/14/2020Morgan StanleyReiterated RatingEqual Weight
i
10/1/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
7/24/2020Main First BankUpgradeHold ➝ Buy
i
7/15/2020Credit Suisse GroupReiterated RatingNeutral
i
7/8/2020UBS GroupReiterated RatingBuy
i
7/6/2020Credit Suisse GroupReiterated RatingNeutral
i
6/29/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
5/13/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
4/29/2020ING GroupDowngradeHold ➝ Sell
i
4/15/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
3/30/2020Morgan StanleyReiterated RatingEqual Weight
i
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
11/27/2019Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
i
8/5/2019ABN AmroDowngradeBuy ➝ Hold
i
7/5/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
2/1/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy
i
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
i
12/1/2017Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
i
3/28/2017Liberum CapitalUpgradeHold ➝ Buy
i
3/9/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
i
1/6/2017BarclaysUpgradeEqual Weight ➝ Overweight
i
10/26/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Underweight
i
(Data available from 2/26/2016 forward)
Koninklijke DSM logo
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, and vitamins; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; coating resins and functional materials; Dyneema, a fiber solution for use in aviation, personal protection, marine, fishing, heavy lifting, and sports and lifestyle industries; and additives. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides anti-reflective (AR) coatings for solar glass, retrofit AR and anti-soiling coatings, and conductive and PV backsheets; and yeast and enzymes for the conversion of starch, corn fiber, and biomass. The company has a partnership with Strait Access Technologies to develop trans-catheter replacement heart valves with polymeric leaflets. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Read More

Today's Range

Now: $42.27
$41.78
$42.61

50 Day Range

MA: $44.06
$42.27
$45.33

52 Week Range

Now: $42.27
$22.86
$45.98

Volume

21,956 shs

Average Volume

43,791 shs

Market Capitalization

$30.68 billion

P/E Ratio

45.95

Dividend Yield

0.90%

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of Koninklijke DSM?

The following Wall Street sell-side analysts have issued reports on Koninklijke DSM in the last twelve months: Barclays PLC, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, ING Group, JPMorgan Chase & Co., Main First Bank AG, Morgan Stanley, Sanford C. Bernstein, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for RDSMY.

What is the current price target for Koninklijke DSM?

0 Wall Street analysts have set twelve-month price targets for Koninklijke DSM in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Koninklijke DSM in the next year.
View the latest price targets for RDSMY.

What is the current consensus analyst rating for Koninklijke DSM?

Koninklijke DSM currently has 2 sell ratings, 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RDSMY, but not buy more shares or sell existing shares.
View the latest ratings for RDSMY.

What other companies compete with Koninklijke DSM?

How do I contact Koninklijke DSM's investor relations team?

Koninklijke DSM's physical mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company's listed phone number is 31-45-578-2864. The official website for Koninklijke DSM is www.dsm.com.